Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0375153B2 - - Google Patents
[go: Go Back, main page]

JPH0375153B2 - - Google Patents

Info

Publication number
JPH0375153B2
JPH0375153B2 JP58232507A JP23250783A JPH0375153B2 JP H0375153 B2 JPH0375153 B2 JP H0375153B2 JP 58232507 A JP58232507 A JP 58232507A JP 23250783 A JP23250783 A JP 23250783A JP H0375153 B2 JPH0375153 B2 JP H0375153B2
Authority
JP
Japan
Prior art keywords
dna
xylanase
medium
microorganism
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58232507A
Other languages
Japanese (ja)
Other versions
JPS60126077A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP58232507A priority Critical patent/JPS60126077A/en
Priority to DK138984A priority patent/DK138984A/en
Priority to FI840843A priority patent/FI85721C/en
Priority to EP88121510A priority patent/EP0316023B1/en
Priority to AT84102440T priority patent/ATE61410T1/en
Priority to EP84102440A priority patent/EP0121138B1/en
Priority to AT88121510T priority patent/ATE90387T1/en
Priority to DE88121510T priority patent/DE3486163T2/en
Priority to DE8484102440T priority patent/DE3484207D1/en
Priority to CA000449095A priority patent/CA1226833A/en
Priority to US06/590,636 priority patent/US4624922A/en
Publication of JPS60126077A publication Critical patent/JPS60126077A/en
Priority to FI890246A priority patent/FI86438C/en
Publication of JPH0375153B2 publication Critical patent/JPH0375153B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01032Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477Hemicellulases not provided in a preceding group
    • C12N9/248Xylanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008Endo-1,4-beta-xylanase (3.2.1.8)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、宿主の微生物細胞内に、生理活性高
分子物質の菌体外生産に関与する特定の遺伝情報
を担うデオキシリボ核酸(DNA)を組み込んだ
プラスミドを含有させてこれを培養し、この特定
の遺伝情報によつて前記高分子物質を菌体外に生
成(分泌)、蓄積させて著量の生産物質を採取す
ることを目的とするものである。特定の遺伝情報
を担うDNAを組み込んだプラスミドを宿主の微
生物に導入し、この微生物を培養することによつ
てアミノ酸、ペプチド等の比較的低分子物質を生
産する方法が提案されているが、高分子物質の生
産能をもつプラスミドは宿主の微生物によつて増
殖の程度が異なり、且つプラスミドの十分な発現
機能を実現することができず、またその有効な培
養方法も確立されていない。 従来、微生物の代謝産物である高分子物質を菌
体外に生産する遺伝情報を担うDNAを組み込ん
だプラスミドによつて他に属に属する微生物を宿
主として形質転換させた場合、特定の生産物のみ
を菌体外に著量に生産せしめることができず、宿
主として通常用い得るエシエリヒア属の微生物で
はプラスミドによる形質転換によつてもこれを達
成することができなかつた。 これに対し、本発明者は、先に、バチルス属に
属する微生物の代謝産物である高分子物質として
ペニシリナーゼの菌体外生産(分泌)に関与する
遺伝情報を担うDNAを組み込んだプラスミドを
エシエリヒア属に属する微生物に導入し、この微
生物の培養方法を見出してその菌体外に、ペニシ
リナーゼ等の酵素蛋白を著量に生産(分泌)せし
め得ることに成功し、前記の目的の達成を初めて
可能とした。 更に、鋭意研究の結果、本発明者は、高分子物
質としてキシラナーゼの菌体外生産(分泌)に関
与する遺伝情報を担うDNAを組み込んだプラス
ミドをエシエリヒア属に属する微生物に導入して
形質転換した新規微生物を得、当該微生物の培養
方法を見出してその菌体外にキシラナーゼ等々の
酵素蛋白によつて代表される高分子物質を著量に
生産(分泌)せしめ得ることに成功して本発明を
完成するに至つた。 本発明において「高分子物質」とは、微生物の
産出する代謝産物である酵素蛋白類、抗生物質
等々の他、動物起源の生理活性蛋白類を包含する
一連の有用な生理活性高分子物質群を指称するも
のである。 以下、本発明方法について詳細に説明する。 本発明方法において用いられる微生物は、エシ
エリヒア属の染色体外遺伝子(プラスミド)とし
て知られるコリシンE1因子等の、培養された細
胞内で増殖し得る形式をとるプラスミド(染色体
外DNAすなわちベクターDNA)に、外来の遺伝
子DNAを組み込んだプラスミドを含有する、エ
シエリヒア・コリによつて代表されるエシエリヒ
ア属に属する微生物である。 前記ベクターDNAに組み込まれる外来遺伝子
(DNA断片)は、特定の高分子物質の菌体外生産
(分泌)に関与する情報を担うDNAであり、高分
子物質、例えばキシラナーゼ、ペニシリナーゼ、
ホスフアターゼ、β−ガラクトシダーゼ、アミラ
ーゼ、プロテアーゼ、β−グルカナーゼ等々の酵
素蛋白類を生産して菌体外に分泌せしめる情報を
担うDNAが挙げられる。 前記外来の遺伝子DNAは、微生物起源の高分
子物質の菌体外生産(分泌)に関与する情報を担
うDNAとして、例えば、バチルス(Bacillus)
属に属する微生物のバチルス・C125菌(微工研
菌寄第7344号)から調製されたDNA断片が有利
に用いられる。 本発明に使用される、キシラナーゼの菌体外生
産に関与する遺伝情報を担うDNAを含有する微
生物の例としては、バチルス・C125菌(微工研
菌寄第7344号)を挙げることができる。バチル
ス・C125菌は埼玉県入間郡鶴ケ島町で採取され
た土壌より分離された微生物であり、次の菌学的
性質を有する。 なお、菌学的性質の試験及び分類方法は、「エ
アロビツク・スポア・ホーミング・バクテリア」
〔“Aerobic Spore−forming Bacteria”(Unitd
State Department of Agriculture、Nov.1952
by N.R.Smith、R.E.Gordon & F.E.Clark)〕
及び「バージエースマニユアル・オブ・デタミネ
イテイブ・バクテリオロジー」(1957年)
〔Bergey′s Manual of Determinative
Bacteriology(1957)〕に基づいて行われた。 Γ菌学的諸性質 (a) 形態 (1) 大きさは0.5〜0.7μ×3.0〜4.0μの桿菌であ
る。 (2) 胞子を形成し、大きさは0.6〜0.8μ×1.0〜
1.2μの卵形であつて、胞子のうはふくらんで
いる。 (3) グラム染色性は陽性である。
The present invention involves culturing a host microbial cell containing a plasmid containing deoxyribonucleic acid (DNA) carrying specific genetic information involved in the extracellular production of bioactive polymeric substances, and culturing the plasmid. The purpose of this method is to produce (secrete) and accumulate the above-mentioned polymeric substance outside the bacterial body using the genetic information of the microorganism, and to collect a significant amount of the produced substance. A method has been proposed to produce relatively low-molecular substances such as amino acids and peptides by introducing a plasmid containing DNA carrying specific genetic information into a host microorganism and culturing this microorganism. Plasmids capable of producing molecular substances have different propagation levels depending on the host microorganism, and it is not possible to achieve a sufficient expression function of the plasmid, and no effective culture method has been established. Conventionally, when a microorganism belonging to another genus is transformed as a host with a plasmid that incorporates DNA carrying the genetic information for producing macromolecular substances, which are metabolites of microorganisms, outside the microbial cell, only specific products can be produced. However, it has not been possible to produce a significant amount of the microorganisms outside the bacterial cells, and this has not been possible even through plasmid-based transformation using microorganisms of the genus Escherichia that can normally be used as hosts. In contrast, the present inventors previously developed a plasmid containing DNA carrying genetic information involved in the extracellular production (secretion) of penicillinase as a polymeric substance that is a metabolite of microorganisms belonging to the genus Bacillus. We discovered a method for culturing this microorganism and succeeded in producing (secretion) a large amount of enzyme proteins such as penicillinase outside of the microorganism, making it possible for the first time to achieve the above objective. did. Furthermore, as a result of intensive research, the present inventor introduced and transformed a microorganism belonging to the genus Escherichia with a plasmid incorporating DNA carrying genetic information involved in the extracellular production (secretion) of xylanase as a polymeric substance. The present invention was achieved by obtaining a new microorganism, finding a method for culturing the microorganism, and successfully producing (secreting) a large amount of polymeric substances represented by enzyme proteins such as xylanase outside the microorganism. It was completed. In the present invention, "polymeric substances" refers to a series of useful bioactive macromolecular substances, including enzyme proteins, antibiotics, etc., which are metabolites produced by microorganisms, as well as bioactive proteins of animal origin. It refers to something. The method of the present invention will be explained in detail below. The microorganism used in the method of the present invention contains a plasmid (extrachromosomal DNA, or vector DNA) in a format that can proliferate in cultured cells, such as the colicin E 1 factor known as an extrachromosomal gene (plasmid) of the genus Escherichia. , a microorganism belonging to the genus Escherichia represented by Escherichia coli, containing a plasmid incorporating foreign genetic DNA. The foreign gene (DNA fragment) incorporated into the vector DNA is DNA that carries information related to extracellular production (secretion) of a specific polymeric substance, such as xylanase, penicillinase,
Examples include DNA that carries information for producing enzyme proteins such as phosphatase, β-galactosidase, amylase, protease, β-glucanase, etc. and secreting them outside the bacterial cell. The foreign gene DNA is DNA that carries information related to the extracellular production (secretion) of macromolecular substances originating from microorganisms, such as Bacillus.
A DNA fragment prepared from the microorganism belonging to the genus Bacillus C125 (Feikoken Bacterium No. 7344) is advantageously used. An example of a microorganism containing DNA carrying genetic information involved in the extracellular production of xylanase used in the present invention is Bacillus C125 (Feikoken Bacteria No. 7344). Bacillus C125 is a microorganism isolated from soil collected in Tsurugashima Town, Iruma District, Saitama Prefecture, and has the following mycological properties. The test and classification method for mycological properties is "Aerobic Spore Homing Bacteria"
[“Aerobic Spore-forming Bacteria” (Unitd
State Department of Agriculture, Nov.1952
by NRSmith, REGordon & FEClark)
and “Burge Ace Manual of Determinative Bacteriology” (1957)
[Bergey's Manual of Determinative
Bacteriology (1957)]. Γ Mycological properties (a) Morphology (1) It is a bacillus with a size of 0.5-0.7μ x 3.0-4.0μ. (2) Forms spores, size 0.6-0.8μ x 1.0-
The sporangium is 1.2 μ in oval shape and swollen. (3) Gram staining is positive.

【表】【table】

【表】【table】

【表】 以上の諸性質を総括すると、前記バチルス・
C125菌は、好気性の有胞子細菌であることから、
バチルス(Bacillus)属に属する微生物であるこ
とは明らかであるが、特に生育し得る範囲がPH/
1.0と55℃までである点において明らかに公知の
菌種と区別され、好アルカリ性細菌の新菌種を認
定することが妥当であると結論された。 前記ベクターDNAとしては、天然に存在する
ものを抽出したものゝ他、増殖に必須な部分以外
のDNAの部分が一部欠落しているものでもよく、
例えばColE1の系統、pMB9の系統、pBR322の
系統、pSC101の系統、R6Kの系統、ラムダーフ
アージの系統等が挙げられる。 また、前記ベクターDNAに前記外来遺伝子
DNAを組み込む方法は、既知のいずれの方法も
適用し得る。例えば、適当な制限酵素
(Endonuclease)を選択、処理してDNAを切断
し、次いで同様に処理した、ベクターとして用い
るDNAと混合し、リガーゼによつて再結合する
方法が用いられる。 このように得られた外来のDNA断片とベクタ
ーDNAの結合物を、形質転換法によつて受容菌
であるエシエリヒア属の微生物の菌体に導入し、
遺伝形質として安定するまで増殖すると、所望の
遺伝形質とベクターDNAの形質を併せもつ形質
転換株が得られる。このようにして得られた微生
物を培養するには、特定の遺伝情報によつて生成
される物質の生産に適した培地であつて且つ宿主
のエシエリヒア属の微生物の生育に適した培地を
用い得るが、本発明方法では、使用培地の組成と
して、生育のために要求される無機塩とともに、
選択された炭素源を必須に含有する培地で生育、
増殖させ、同一培地で菌体量が最大に達したとき
から実質的に前記培地中に代謝産物である高分子
物質の生成、蓄積が停止するまでの時間中、その
まま培養を継続することが必要である。無機塩と
しては、特に塩化ナトリウムが有効であり、また
塩化カリウムも用い得る。無機塩を含有する培地
としては、グルコース、シユークロース、ラクト
ース、マルトース、グリセロール、〓、キシラン
等々の炭素源、アンモニア水、アンモニウム塩等
の窒素源、無機イオンの他に、必要に応じてアミ
ノ酸、ビタミン等の栄養素を含有させることがで
き、特に前記炭素源の影響は重要であり、生産物
質に応じて適宜選択し、添加することが必要であ
る。通常、エシエリヒア.コリの生育培地として
用いられるLB培地(トリプトン、酵母エキス、
食塩)、BPB培地(Difco;ポリペプトン、酵母
エキス、リン酸カリウム)、栄養.寒天培地
(Difco0001)、トリプトン.食塩培地等を基本培
地として調製したものを用いればよい。 無機塩を含まない前記の培地では、80%以上の
物質が菌体内で生産されるので、生成物質のほと
んどを菌体外に生産させるためには無機塩の存在
は必須である。また、無機塩の使用量は、培地組
成に対してほゞ0.5〜3.0%が適当である。 炭素源の影響は、前記LB培地に〓及び/又は
キシランを加えたときに特にすぐれた結果が得ら
れ、培地組成に対してそれぞれほゞ0.5%量の添
加が望ましい。 培養方法は、PH、温度、酸素供給量等の条件と
してエシエリヒア属の微生物の生育に適した条件
を採り得るが、前記微生物を培地に接種した後、
前記微生物が生育してその菌体量が最大に達した
とき、即ち対数増殖後期から実質的に培地中に高
分子物質の生成、蓄積が停止するまでの時間中、
同一培地で培養をそのまま継続することが必要で
ある。 エシエリヒア属の微生物の前記菌体量が最大に
達したときから実質的に培地中に高分子物質の生
成、蓄積が停止するまでの時間は、ほぼ12〜48時
間の範囲である。なお、PH条件は特に影響されな
いが、PH5〜8の範囲、特にPH7が適当である。
かくして、培養中に生育のために要求される無機
塩及び炭素源その他の成分を培地に更に添加する
ことなく、前記微生物の菌体外に高分子物質が著
量に生産(分泌)され、有利に採取し得る。 本発明方法によつて、生産物質は目的とする単
一の高分子物質のみならず、複数の酵素蛋白類が
それぞれ菌体外に著量に生産(分泌)され、併せ
て採取することができる。即ち、前記エシエリヒ
ア・コリHB101(pC×311)株の培養により、キ
シラナーゼと共にペニシリナーゼや従来、菌体内
にのみ検出されていたアルカリホスフアターゼ
が、後述の実施例に記載の如く、それぞれ菌体外
に著量に分泌されることが明らかにされた。これ
は、本発明によつて得られる後述のプラスミド
(pC×311)に含まれる約4000の塩基対のDNA
が、代謝産物の菌体外生産(分泌)能を宿主に附
与していることを意味するものである。 本発明の培養方法により、酵素蛋白の他、抗生
物質、多糖類その他の高分子発酵生産物を著量に
生産することができ、また更に、外来の生理活性
高分子物質の生産の遺伝情報を担うDNAと生理
活性高分子物質の菌体外選択生産(分泌)に関与
する遺伝情報を担うDNAとを併せもつプラスミ
ドを利用することによつて、インシユリン等のホ
ルモンペプチドやインターフエロン抗体等の生理
活性蛋白の大量生産法にも適用し得るので、有用
高分子物質の工業的発酵生産に寄与するところ極
めて大である。 以下に、本発明方法の一例として、酵素蛋白の
キシラナーゼの場合について説明する。まずその
菌体外生産(分泌)遺伝情報を担うDNAを組み
込んだプラスミドによるエシエリヒア・コリの形
質転換株の調製を例示する。 (1) キシラナーゼ生産能の遺伝情報をもつDNA
の調製 キシラナーゼを菌体外に生成、蓄積する能力
を有する好アルカリ性のバチルス・C125菌
(微工研菌寄第7344号)を培地〔(g/):〓
10.0、酵母エキス5.0、ポリペプトン5.0、
K2HPO41.0、MgSO4・7H2O0.2をNa2CO310で
PH6.0に調整したもの〕中、30℃で19時間振盪
培養を行ない、対数増殖後期の菌体を集菌後、
フエノール法によるDNA抽出法によつてDNA
を抽出、精製し、DNA5mgを得た。 (2) DNA断片のベクターへの挿入 (1)で得たDNA10μgをとり、制限エンドヌ
クレアーゼHind を加え、37℃で5分、10
分、20分、30分、60分反応させて部分的に切断
した。一方、ベクターとして用いるテトラサイ
クリン抵抗性(Tetr)とアンピシリン抵抗性
(Ampr)をもつpBR322プラスミドDNA
(Bethesda Research Laboratories社(米国)
製)をHind で完全に切断して65℃、5分
の熱処理後、前者と混合し、T4フアージ由来
のDNAリガーゼによつて10℃、24時間DNA鎖
の連結反応を行ない、65℃、5分の熱処理後、
反応液に2倍容のエタノールを加えてDNAを
組み込んだプラスミドDNAを沈澱、採取した。 (3) キシラナーゼの菌体外生産(分泌)遺伝子を
担うプラスミドによる形質転換 エシエリヒア・コリK−12株とエシエリヒ
ア・コリB株のハイブリツド株であるエシエリ
ヒア・コリHB101株〔Molecular Cloning A
Laboratory Manual p.504(1982)参照〕
(遺伝形質:F-、hsdS20(r- B、m- B)、rec
A13、ara-14、pro A2、lac Y1、gal K2、
rps L20(Sm1)、xyl−5、mtl−1、sup
E44λ-)をLB培地(純水1当りトリプトン
(Difco)10g、酵母エキス5g、グルコース
1g、NaCl10gを含み、PH7.0に調製したも
の)10mlに接種し、37℃で振盪培養を行ない、
対数増殖後期まで生育させた後に集菌した。こ
れを氷冷下、最終濃度で0.03M CaCl2の溶液に
順次懸濁させてコンピテントな細胞とした。こ
の細胞懸濁液に(2)で得たプラスミドDNAの溶
解液を加えて氷冷下で60分反応させ、42℃、1
〜2分間ヒートシヨツクを与えて前記プラスミ
ドDNAを細胞内に取り込ませた。次いで、こ
の細胞懸濁液を別途、前記LB培地に接種し、
37℃、3〜5時間振盪培養して形質転換反応を
行なつた後、集菌、洗滌して形質転換株を得、
そのなかからエシエリヒア・コリHB101
(pCX311)(微工研菌寄第7345号)(FERMP−
7345)を得た。この形質転換株のプラスミド
(pC×311)は、キシラナーゼの菌体外生産
(分泌)に関与する遺伝情報を担うキシラナー
ゼDNA断片が組み込まれているDNA円形分
子、即ちpBR322プラスミドDNAと約4000の
塩基対のDNAから成る9.01Kbの新規なDNA
円形分子であり、その制限酵素切断地図は第4
図に示すとおりである。 実施例 1 前記(3)で得られた形質転換株、エシエリヒア・
コリHB101(pC×311)(微工研菌寄第7345号)
(FERMP−7345)を、LB培地(1当りトリプ
トン10g、酵母エキス5g、グルコース1g、グ
リセロール2g、NaCl10g、ペニシリン10mgを
含む)100mlに0.5%のキシランを含む500ml容の
フラスコで37℃にて振盪培養した。細胞の生育
(菌体量の測定は、660nmの吸光度(OD)で、
酵素活性は、酵素液0.005mlにキシラン液(生化
学工業(株)製)0.1ml及びPH8.0の0.2Mトリスマレイ
ト緩衝液0.1mlを加えて40℃で10分間反応させ、
DNS(3,5−dinitrosalicylic acid)1mlを加
えて100℃で5分間反応させた後に水4mlを加え
て510mμの吸光度を測定し、1分間にキシロー
ス1mgの還元力を生ずる酵素量をキシラナーゼ1
単位(U)とした。 第1図は、前記LB培地に0.5%キシランを加え
た培地を用いた場合のキシラナーゼの活性、即ち
キシラナーゼの菌体外生産(分泌)能を示すグラ
フである。 前記形質転換株の菌体量は接種後、9〜12時間
で最大に達し、第1図に示すとおり、菌体外キシ
ラナーゼの活性はほぼ6時間後から増大しはじ
め、13時間後に最大に達した(≒0.35U/ml)。
生産されたキシラナーゼは非常に安定であり、第
1図に示されるように、更にそのまま培養を48時
間まで継続しても生産量は減少せず、全酵素活性
の80%以上に達した。これに対して、菌体内キシ
ラナーゼは、培養初期(接種後9時間)において
若干認められたが、その生産は全酵素活性の10%
程度であり、最高で0.13U/mlに過ぎず、しかも
その活性は徐々に減少した。 また、第2図は、前記LB培地にキシランに代
えて0.5%の〓を加えた培地を用いた場合のキシ
ラナーゼの活性を示すグラフであり、第1図の場
合とほゞ同様の傾向が認められた。なお、比較と
して、DNA供与菌の前記バチルス・C125菌(微
工研菌寄第7344号)を培養してキシラナーゼ活性
を測定した。 前記バチルス・C125菌の場合は、使用培地
〔(g/):キシラン10.0、酵母エキス5.0、ポリ
ペプトン5.0、K2HPO41.0、MgSO4・7H2O、0.2
をNa2CO310でPH9.0に調整したもの〕100mlを含
む500ml容のフラスコに接種し、37℃で振盪培養
した。 培養液の菌体外キシラナーゼ活性を8時間毎に
測定した。接種後、8時間で徐々に活性が上が
り、48時間に至つてやつと活性は最高(0.5U/
ml)に達したが、以後急速に活性は減少した(第
3図参照)。 実施例 2 前記エシエリヒア・コリHB101(pCX311)(微
工研菌寄第7345号)(FERMP−7345)の菌体外
キシラナーゼ生産について、培地中における無機
塩の影響を比較した。なお、培養条件は実施例1
と同様である。 即ち、実施例1の培地を基本培地とし、これに
無機塩を添加して14時間および20時間、それぞれ
培養し、無機塩の影響を調べた。 この結果を第1表に示す。
[Table] To summarize the above properties, the above-mentioned Bacillus
Since C125 bacteria is an aerobic spore-forming bacterium,
It is clear that it is a microorganism belonging to the genus Bacillus, but the range in which it can grow is
1.0 and up to 55°C, it was clearly distinguished from known bacterial species, and it was concluded that it was appropriate to recognize it as a new alkalophilic bacterial species. The vector DNA may be extracted from naturally occurring DNA, or may be one in which part of the DNA other than the part essential for proliferation is missing.
Examples include ColE 1 strain, pMB9 strain, pBR322 strain, pSC101 strain, R6K strain, lambda phage strain, and the like. Further, the foreign gene may be added to the vector DNA.
Any known method can be applied to incorporate DNA. For example, a method is used in which DNA is selected and treated with an appropriate restriction enzyme (Endonuclease) to cleave the DNA, then mixed with similarly treated DNA to be used as a vector, and religated with ligase. The conjugate of the foreign DNA fragment and vector DNA thus obtained is introduced into the cells of a recipient microorganism of the genus Escherichia by a transformation method,
When the vector is grown until the genetic trait is stable, a transformed strain having both the desired genetic trait and the vector DNA trait can be obtained. To culture the microorganism thus obtained, a medium suitable for producing a substance produced by specific genetic information and suitable for the growth of the host microorganism of the genus Escherichia can be used. However, in the method of the present invention, the composition of the medium used includes inorganic salts required for growth,
Grow in a medium that essentially contains the selected carbon source,
It is necessary to continue culturing as it is from the time when the number of bacterial cells reaches the maximum in the same medium until the production and accumulation of macromolecular substances, which are metabolites, substantially cease in the medium. It is. As the inorganic salt, sodium chloride is particularly effective, and potassium chloride can also be used. The medium containing inorganic salts includes carbon sources such as glucose, sucrose, lactose, maltose, glycerol, xylan, etc., nitrogen sources such as aqueous ammonia and ammonium salts, and inorganic ions, as well as amino acids and vitamins as necessary. The influence of the carbon source is especially important, and it is necessary to select and add nutrients as appropriate depending on the substance to be produced. Usually Escherichia. LB medium (tryptone, yeast extract,
Salt), BPB medium (Difco; polypeptone, yeast extract, potassium phosphate), nutrition. Agar medium (Difco0001), tryptone. A basic medium prepared from a saline medium or the like may be used. In the above-mentioned medium that does not contain inorganic salts, more than 80% of the substances are produced within the bacterial cells, so the presence of inorganic salts is essential in order to produce most of the produced substances outside the bacterial cells. The appropriate amount of inorganic salt to be used is approximately 0.5 to 3.0% based on the medium composition. Regarding the influence of the carbon source, particularly excellent results are obtained when 〓 and/or xylan are added to the LB medium, and it is desirable to add each in an amount of about 0.5% based on the medium composition. The culture method can adopt conditions suitable for the growth of microorganisms of the genus Escherichia, such as pH, temperature, oxygen supply, etc., but after inoculating the microorganisms into the medium,
During the period from when the microorganism grows and reaches its maximum cell mass, that is, from the late stage of logarithmic growth until production and accumulation of polymeric substances in the medium substantially cease,
It is necessary to continue culturing in the same medium. The time from when the amount of microorganisms of the genus Escherichia reaches the maximum until production and accumulation of polymeric substances in the medium substantially ceases is approximately 12 to 48 hours. Note that the pH condition is not particularly affected, but a pH range of 5 to 8, particularly a pH of 7, is suitable.
In this way, a significant amount of polymeric substances can be produced (secreted) outside the cells of the microorganism without further adding inorganic salts, carbon sources, and other components required for growth to the medium during culture, which is advantageous. It can be collected. By the method of the present invention, not only a single target polymeric substance but also multiple enzyme proteins are produced (secreted) in large amounts outside the bacterial cells, and can be collected together. . That is, by culturing the Escherichia coli HB101 (pC It was revealed that it was secreted in significant amounts. This is approximately 4000 base pairs of DNA contained in the plasmid (pC×311) described below obtained by the present invention.
This means that the host is endowed with the ability to produce (secrete) metabolites outside the cell. By the culture method of the present invention, in addition to enzyme proteins, antibiotics, polysaccharides, and other polymeric fermentation products can be produced in large quantities, and genetic information for the production of foreign physiologically active polymeric substances can also be obtained. By using a plasmid that has DNA that carries genetic information involved in the extracellular selective production (secretion) of physiologically active polymeric substances, it is possible to suppress physiological effects such as hormone peptides such as insulin and interferon antibodies. Since it can be applied to mass production of active proteins, it will greatly contribute to the industrial fermentation production of useful polymeric substances. The case of xylanase, an enzyme protein, will be explained below as an example of the method of the present invention. First, we will exemplify the preparation of a transformed strain of Escherichia coli using a plasmid incorporating DNA carrying the genetic information for extracellular production (secretion). (1) DNA with genetic information for xylanase production ability
Preparation of Bacillus C125, an alkalophilic bacterium that has the ability to produce and accumulate xylanase outside the bacterial body (Feikoken Bacteria No. 7344), in a medium [(g/):〓
10.0, yeast extract 5.0, polypeptone 5.0,
K 2 HPO 4 1.0, MgSO 4 7H 2 O 0.2 in Na 2 CO 3 10
After culturing with shaking at 30°C for 19 hours in a medium (adjusted to pH 6.0), the cells were harvested at the late stage of logarithmic growth.
DNA by phenol method DNA extraction method
was extracted and purified to obtain 5 mg of DNA. (2) Insertion of DNA fragment into vector Take 10μg of DNA obtained in (1), add restriction endonuclease Hind, and incubate at 37°C for 5 minutes.
It was allowed to react for 20 minutes, 30 minutes, and 60 minutes for partial cleavage. On the other hand, pBR322 plasmid DNA with tetracycline resistance (Tet r ) and ampicillin resistance (Amp r ) used as a vector
(Bethesda Research Laboratories (USA)
(manufactured by Hind) was completely cleaved with Hind, heat treated at 65℃ for 5 minutes, mixed with the former, and the DNA strands were ligated using T4 phage-derived DNA ligase at 10℃ for 24 hours. After 5 minutes of heat treatment,
Two volumes of ethanol was added to the reaction solution to precipitate and collect the plasmid DNA into which the DNA had been incorporated. (3) Transformation with a plasmid carrying the extracellular production (secretion) gene of xylanase Escherichia coli HB101 strain, which is a hybrid strain of Escherichia coli K-12 strain and Escherichia coli B strain [Molecular Cloning A
See Laboratory Manual p.504 (1982)]
(genetic traits: F- , hsdS20(r - B , m - B ), rec
A13, ara - 14, pro A2, lac Y1, gal K2,
rps L20 (Sm 1 ), xyl-5, mtl-1, sup
E44λ - ) was inoculated into 10 ml of LB medium (containing 10 g of tryptone (Difco), 5 g of yeast extract, 1 g of glucose, and 10 g of NaCl per pure water, adjusted to pH 7.0), and cultured with shaking at 37°C.
Bacteria were harvested after growing to the late logarithmic growth stage. This was sequentially suspended in a solution of 0.03M CaCl 2 at a final concentration under ice cooling to obtain competent cells. Add the plasmid DNA lysate obtained in (2) to this cell suspension, react for 60 minutes on ice, and heat at 42℃ for 1 hour.
A heat shock was applied for ~2 minutes to incorporate the plasmid DNA into the cells. Next, this cell suspension was separately inoculated into the LB medium,
After carrying out a transformation reaction by culturing with shaking at 37°C for 3 to 5 hours, the cells were harvested and washed to obtain a transformed strain.
Among them Esierhia coli HB101
(pCX311) (FERMP-
7345) was obtained. The plasmid of this transformed strain (pC 9.01Kb of novel DNA consisting of paired DNA
It is a circular molecule, and its restriction enzyme cleavage map is
As shown in the figure. Example 1 The transformed strain obtained in (3) above, Escherichia
Cori HB101 (pC×311) (Feikoken Bacillus No. 7345)
(FERMP-7345) was shaken at 37°C in a 500 ml flask containing 0.5% xylan in 100 ml of LB medium (each containing 10 g of tryptone, 5 g of yeast extract, 1 g of glucose, 2 g of glycerol, 10 g of NaCl, and 10 mg of penicillin). Cultured. Cell growth (measurement of bacterial mass is by absorbance (OD) at 660 nm,
Enzyme activity was determined by adding 0.1 ml of xylan solution (manufactured by Seikagaku Corporation) and 0.1 ml of 0.2M trismalate buffer with pH 8.0 to 0.005 ml of the enzyme solution and reacting at 40°C for 10 minutes.
Add 1 ml of DNS (3,5-dinitrosalicylic acid) and react at 100℃ for 5 minutes, then add 4 ml of water and measure the absorbance at 510 mμ.
The unit is (U). FIG. 1 is a graph showing the xylanase activity, ie, the extracellular production (secretion) ability of xylanase, when using a medium prepared by adding 0.5% xylan to the LB medium. The cell mass of the transformed strain reached its maximum 9 to 12 hours after inoculation, and as shown in Figure 1, the extracellular xylanase activity began to increase approximately 6 hours later and reached its maximum 13 hours later. (≒0.35U/ml).
The produced xylanase was very stable, and as shown in Figure 1, even if the culture was continued for up to 48 hours, the production amount did not decrease and reached more than 80% of the total enzyme activity. In contrast, intracellular xylanase was slightly observed in the early stage of culture (9 hours after inoculation), but its production accounted for 10% of the total enzyme activity.
The maximum activity was only 0.13 U/ml, and its activity gradually decreased. In addition, Figure 2 is a graph showing the xylanase activity when using the LB medium to which 0.5% 〓 was added instead of xylan, and almost the same trend as in Figure 1 was observed. It was done. For comparison, the DNA-donor Bacillus C125 (Keiken Bacteria No. 7344) was cultured and the xylanase activity was measured. In the case of Bacillus C125, the medium used [(g/): xylan 10.0, yeast extract 5.0, polypeptone 5.0, K 2 HPO 4 1.0, MgSO 4 7H 2 O, 0.2
[adjusted to pH 9.0 with Na 2 CO 3 10]] was inoculated into a 500 ml flask containing 100 ml of the phage, and cultured with shaking at 37°C. The extracellular xylanase activity of the culture solution was measured every 8 hours. After inoculation, the activity gradually increased 8 hours after inoculation, and by 48 hours, the activity was the highest (0.5U/
ml), but the activity rapidly decreased thereafter (see Figure 3). Example 2 The influence of inorganic salts in the medium was compared on extracellular xylanase production of Escherichia coli HB101 (pCX311) (FERMP-7345). The culture conditions are the same as in Example 1.
It is similar to That is, the medium of Example 1 was used as a basic medium, and inorganic salts were added thereto and cultured for 14 hours and 20 hours, respectively, to examine the influence of the inorganic salts. The results are shown in Table 1.

【表】【table】

【表】 実施例 3 前記エシエリヒア・コリHB101(pCX311)(微
工研菌寄第7345号)(FERM P−7345)の菌体
外生産物質について、プラスミド(pCX311)を
導入しないエシエリヒア・コリHB101株及び
pBR322プラスミドを導入したエシエリヒア・コ
リHB101株の生産物質と比較して、キシラナー
ゼ以外の酵素蛋白類を調べた結果を第2表に示
す。 なお、培養条件は、実施例1のキシランを加え
たLB培地で、ペニシリナーゼについては、37℃
にて20時間振盪培養し、アルカリホスフアターゼ
及びβ−ガラクトシダーゼについては、15時間そ
れぞれ培養した。また、アルカリホスフアターゼ
及びβ−ガラクトシダーゼの酵素活性は、波長
420nmにおける吸光度(OD)を測定して表わし
たものである。
[Table] Example 3 Regarding the extracellularly produced substances of Escherichia coli HB101 (pCX311) (FERM P-7345) (FERM P-7345), Escherichia coli HB101 strain into which the plasmid (pCX311) was not introduced as well as
Table 2 shows the results of examining enzyme proteins other than xylanase in comparison with the substances produced by Escherichia coli HB101 strain into which the pBR322 plasmid was introduced. The culture conditions were the xylan-added LB medium of Example 1, and the culture conditions for penicillinase were 37°C.
The cells were cultured with shaking for 20 hours, and alkaline phosphatase and β-galactosidase were cultured for 15 hours each. In addition, the enzymatic activities of alkaline phosphatase and β-galactosidase are
It is expressed by measuring the absorbance (OD) at 420 nm.

【表】 参考例 実施例1の形質転換株の培養液に硫酸アンモニ
ウムを加えて塩析した後、沈澱を水に溶かして一
夜流水で透析し、PH4.5の20mM燐酸−燐酸1ソ
ーダー緩衝液で平衡化したCMセルロースに吸着
させた後に食塩濃度を0.1Mから0.7Mまで変化さ
せてキシラナーゼを溶出させると、0.4M前後で
溶出される。活性のある区分を集めてセフアデツ
クス・G−100(Sephadex G−100)によるゲル
過を行つて精製キシラナーゼを得た。また、前
記バチルス・C125菌(微工研菌寄第7344号)の
培養液を同様に処理して精製し、同様なキシラナ
ーゼを得た。 両者のキシラナーゼの同一性をみるために、PH
活性、超遠心分析、電気泳動及び分子量等を測定
したところ、次のとおり両者の同一性が確認され
た。 (a) PH4〜5は酢酸塩、PH5〜8はトリスマレイ
ト、PH7〜9はトリス塩酸、PH9〜11はグリシ
ン苛性ソーダを用いて夫々調整し、前記測定法
によつてPHの影響を調べた結果、第5図のとお
り、両酵素のPH活性の同一性が明らかにされ
た。 (b) 超遠心分析では、両酵素ともに沈降定数約
3.5Sの単一ピークを示した。 (c) PH8.3のデイスク電気泳動で両酵素ともに一
本のバンドになつており、アンフオラインによ
るエレクトロホーカシングで単一のピークを示
し、等電点は6.3にあつた。 (d) 分子量は、両酵素ともにSDS−ポリアクリル
アミド法により約40000と測定された。
[Table] Reference Example After adding ammonium sulfate to the culture solution of the transformed strain of Example 1 and salting out, the precipitate was dissolved in water and dialyzed against running water overnight, and then diluted with 20mM phosphoric acid-phosphoric acid 1 sodium buffer at pH 4.5. When xylanase is adsorbed onto equilibrated CM cellulose and eluted by changing the salt concentration from 0.1M to 0.7M, it is eluted at around 0.4M. The active fractions were collected and subjected to gel filtration using Sephadex G-100 to obtain purified xylanase. In addition, the culture solution of Bacillus C125 (Feikoken Bacteria No. 7344) was treated and purified in the same manner to obtain a similar xylanase. In order to see the identity of both xylanases, PH
As a result of measurements of activity, ultracentrifugation, electrophoresis, molecular weight, etc., the identity of the two was confirmed as follows. (a) PH4 to 5 was adjusted using acetate, PH5 to 8 was adjusted using trismalate, PH7 to 9 was adjusted using tris-hydrochloric acid, and PH9 to 11 was adjusted using glycine caustic soda, and the influence of PH was investigated using the above measurement method. As shown in Figure 5, the identity of the PH activities of both enzymes was revealed. (b) In ultracentrifugation analysis, both enzymes have a sedimentation constant of approx.
It showed a single peak of 3.5S. (c) Disk electrophoresis at pH 8.3 revealed that both enzymes formed a single band, and electrofocusing with ampholine showed a single peak, with an isoelectric point of 6.3. (d) The molecular weight of both enzymes was determined to be approximately 40,000 by the SDS-polyacrylamide method.

【図面の簡単な説明】[Brief explanation of drawings]

第1図及び第2図は、本発明方法で用いたエシ
エリヒア・コリHB101(pCX311)によるキシラ
ナーゼ生産活性を、第3図は、バチルス・C125
菌によるキシラナーゼ生産活性をそれぞれ示すグ
ラフである。第4図は、エシエリヒア・コリ
HB101(pCX311)のプラスミド(pCX311)の制
限酵素切断地図であり、第5図は、エシエリヒ
ア・コリ101(pCX311)とバチルス・C125菌の産
生するキシラナーゼのPH活性の同一性を示すグラ
フである。
Figures 1 and 2 show the xylanase production activity of Escherichia coli HB101 (pCX311) used in the method of the present invention, and Figure 3 shows the xylanase production activity of Bacillus C125.
3 is a graph showing the xylanase production activity of bacteria. Figure 4 shows Escherichia coli.
This is a restriction enzyme cleavage map of the plasmid (pCX311) of HB101 (pCX311), and FIG. 5 is a graph showing the identity of the PH activities of xylanase produced by Escherichia coli 101 (pCX311) and Bacillus C125.

Claims (1)

【特許請求の範囲】[Claims] 1 バチルス(Bacillus)・C125菌の代謝産物で
あるキシラナーゼの菌体外選択生産に関与する遺
伝情報を担うデオキシリボ核酸(DNA)、また
は、該DNAとキシラナーゼ以外の蛋白質をコー
ドするDNAとを組み込んだプラスミドを含有す
るエシエリヒア(Escherichia)属に属する微生
物を、生育のために要求される無機塩を含有する
培地に接種し、接種後、前記微生物の菌体量が最
大に達したときから実質的に前記培地中にキシラ
ナーゼ、または、キシラナーゼと前記蛋白質の生
成、蓄積が停止するまでの時間中、培養をそのま
ま継続することによつて、前記微生物の菌体外に
キシラナーゼ、または、キシラナーゼと前記蛋白
質とを生成せしめることを特徴とする微生物の培
養方法。
1 Incorporating deoxyribonucleic acid (DNA), which carries genetic information involved in the extracellular selective production of xylanase, a metabolite of Bacillus C125 bacteria, or this DNA and DNA encoding a protein other than xylanase. A microorganism belonging to the genus Escherichia containing a plasmid is inoculated into a medium containing an inorganic salt required for growth. By continuing the culture until the production and accumulation of xylanase or xylanase and the protein in the medium stops, the xylanase or xylanase and the protein are released outside the microorganism. A method for culturing microorganisms, characterized by producing.
JP58232507A 1983-03-08 1983-12-09 Culture of microorganism Granted JPS60126077A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP58232507A JPS60126077A (en) 1983-12-09 1983-12-09 Culture of microorganism
DK138984A DK138984A (en) 1983-03-08 1984-02-29 PLASMID, METHOD OF PRODUCING IT, MICROORGANISMS CONTAINING SAME AND PROCEDURE FOR CULTIVATING THE MICROORGANISM
FI840843A FI85721C (en) 1983-03-08 1984-03-02 FOERFARANDE FOER EXTRACELLULAER PRODUKTION AV PENICILLINAS, PLASMID ANVAEND VID FOERFARANDET OCH FOERFARANDE FOER KONSTRUKTION AV PLASMIDEN.
DE88121510T DE3486163T2 (en) 1983-03-08 1984-03-07 Plasmids, processes for their preparation, microorganisms containing them and methods for extracellular production of xylanase by culturing these microorganisms.
AT84102440T ATE61410T1 (en) 1983-03-08 1984-03-07 PLASMIDS, METHODS FOR THEIR PREPARATION, MICROORGANISMS CONTAINING SUCH PLASMIDS AND METHODS FOR CULTIVATION OF THE MICROORGANISMS.
EP84102440A EP0121138B1 (en) 1983-03-08 1984-03-07 Plasmids, methods for contruction of the same, microorganisms carrying the plasmids and methods for cultivation of the microorganisms
AT88121510T ATE90387T1 (en) 1983-03-08 1984-03-07 PLASMIDS, PROCESSES FOR THEIR PRODUCTION, MICROORGANISMS CONTAINING THEM, AND METHODS FOR THE EXTRACELLULAR PRODUCTION OF XYLANASE BY GROWING THESE MICROORGANISMS.
EP88121510A EP0316023B1 (en) 1983-03-08 1984-03-07 Plasmids, methods for their construction, microorganisms carrying them and methods for the extracellular production of xylanase by cultivation of the microorganisms
DE8484102440T DE3484207D1 (en) 1983-03-08 1984-03-07 PLASMIDES, METHODS FOR PREPARING THEM, MICROORGANISMS CONTAINING THESE PLASMIDES, AND METHOD FOR CULTIVATING THE MICROORGANISMS.
CA000449095A CA1226833A (en) 1983-03-08 1984-03-08 Plasmids, methods for construction of the same, microorganisms carrying the plasmids and methods for cultivation of the microorganism
US06/590,636 US4624922A (en) 1983-12-09 1984-03-19 Plasmid, method for construction of the same, microorganism carrying the plasmid and method for cultivation of the microorganism
FI890246A FI86438C (en) 1983-03-08 1989-01-17 Plasmids Inducing Extracellular Secretion of Xylanase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58232507A JPS60126077A (en) 1983-12-09 1983-12-09 Culture of microorganism

Publications (2)

Publication Number Publication Date
JPS60126077A JPS60126077A (en) 1985-07-05
JPH0375153B2 true JPH0375153B2 (en) 1991-11-29

Family

ID=16940408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58232507A Granted JPS60126077A (en) 1983-03-08 1983-12-09 Culture of microorganism

Country Status (1)

Country Link
JP (1) JPS60126077A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756495A (en) * 1980-09-24 1982-04-05 Kyowa Hakko Kogyo Co Ltd Novel dna-introduction vector and recombinant dna

Also Published As

Publication number Publication date
JPS60126077A (en) 1985-07-05

Similar Documents

Publication Publication Date Title
EP0120693B1 (en) Maltogenic amylase enzyme product, preparation and use thereof
Cornet et al. Characterization of two cel (cellulose degradation) genes of Clostridium thermocellum coding for endoglucanases
US4469791A (en) Genetically engineered microorganisms for massive production of amylolytic enzymes and process for preparing same
US4624922A (en) Plasmid, method for construction of the same, microorganism carrying the plasmid and method for cultivation of the microorganism
US4861718A (en) Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof
BG60920B2 (en) METHOD FOR STABLE GENE AMPLIFICATION OF CHROMOSOMAL DNA OF PROKARYOTIC MICROORGANISMS
JP3492935B2 (en) Plasmid vector
US5290916A (en) Purified glucanase enzymes
US3697378A (en) Dextrinization of starch with alph-amylase from bacillus coaculans
JPH0375153B2 (en)
EP0121138A1 (en) Plasmids, methods for contruction of the same, microorganisms carrying the plasmids and methods for cultivation of the microorganisms
EP0316023B1 (en) Plasmids, methods for their construction, microorganisms carrying them and methods for the extracellular production of xylanase by cultivation of the microorganisms
JPH0142675B2 (en)
US4962055A (en) Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
EP0216080A2 (en) Novel plasmids and transformants
EP0187382B1 (en) Plasmid, method for construction of the same, microorganism carrying the plasmid and method for cultivation of the microorganism
JPH0355105B2 (en)
JPH0522508B2 (en)
JP2833793B2 (en) Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase
FI86438B (en) Plasmids which induce extracellular secretion of xylanase, methods for production thereof, and methods for production of xylanase
US5190874A (en) Method for producing penicillinase and xylanase
US5246839A (en) Secretion plasmid comprising the kilgene
JPH0142674B2 (en)
JP2592289B2 (en) DNA fragment containing alkaline cellulase gene, vector incorporating the DNA fragment, and microorganism containing the same
JP2913411B2 (en) Cellulase gene